Analyst Price Target is $54.00
▲ +27.27% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for IRadimed in the last 3 months. The average price target is $54.00, with a high forecast of $60.00 and a low forecast of $48.00. The average price target represents a 27.27% upside from the last price of $42.43.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in IRadimed. This Buy consensus rating has held steady for over two years.
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.